Judith H Maselli
Biographic Data
| ID | 5545984 |
|---|---|
| NAME | Judith H Maselli |
| GIVEN NAMES | Judith H |
| FAMILY NAME | Maselli |
| SIGNATURE | MASELLI J H |
| AFFILIATIONS | University of California, San Francisco |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2008 |
| LATEST PUBLICATION YEAR | 2009 |
| H-INDEX | 0 |
Changes in Prescribing of Antiviral Medications for Influenza Associated With New Treatment Guidelines
In 2006, the Centers for Disease Control and Prevention recommended discontinuing the use of adamantanes (amantadine and rimantadine) to treat influenza because of high levels of resistance to this class of antivirals. We examined changes in prescribing practices resulting from this recommendation and found that prescribing of adamantanes declined nationwide, with these drugs accounting for approximately 40% of the antivirals prescribed for influ…
Get Smart Colorado”
CONTEXT: Large-scale strategies are needed to reduce overuse of antibiotics in US communities. OBJECTIVES: To evaluate the impact of a mass media campaign-"Get Smart Colorado"-on public exposure to campaign, antibiotic use, and office visit rates. DESIGN: Nonrandomized controlled trial. SETTING: Two metropolitan communities in Colorado, United States. SUBJECTS: The general public, managed care enrollees, and physicians residing in the mass media …
No prominent works on this page.
Get Smart Colorado”
CONTEXT: Large-scale strategies are needed to reduce overuse of antibiotics in US communities. OBJECTIVES: To evaluate the impact of a mass media campaign-"Get Smart Colorado"-on public exposure to campaign, antibiotic use, and office visit rates. DESIGN: Nonrandomized controlled trial. SETTING: Two metropolitan communities in Colorado, United States. SUBJECTS: The general public, managed care enrollees, and physicians residing in the mass media …
Changes in Prescribing of Antiviral Medications for Influenza Associated With New Treatment Guidelines
In 2006, the Centers for Disease Control and Prevention recommended discontinuing the use of adamantanes (amantadine and rimantadine) to treat influenza because of high levels of resistance to this class of antivirals. We examined changes in prescribing practices resulting from this recommendation and found that prescribing of adamantanes declined nationwide, with these drugs accounting for approximately 40% of the antivirals prescribed for influ…
Family medicine (2 works) · Medicine (2 works) · Public health (2 works) · Advertising (1 works) · Amantadine (1 works) · Antibiotic Use and Resistance (1 works) · Business (1 works) · Child and Adolescent Health (1 works) · Coronavirus disease 2019 (COVID-19) (1 works) · Disease (1 works)